Clinical Trials List
2020-12-01 - 2025-12-31
Phase I
Recruiting6
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- MING-YANG WANG Division of General Surgery
- Wei-Wu Chen Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 林柏翰 Division of General Internal Medicine
- WEI-LI MA Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Chung Wu Division of General Surgery
- 黃至豪 Division of General Surgery
- Liang-Chih Liu Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ling-Ming Tseng Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 賴亦貞 Division of Radiology
- Yi-Fang Tsai Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- 邱仁輝 Division of General Surgery
- 林燕淑 Division of General Surgery
- 馮晉榮 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- Yi-Jen Chen Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Zhu-Jun Loh Division of General Surgery
- Wei-Pang Chung Division of Hematology & Oncology
- 黃建璋 Division of General Surgery
- Ya-Ting Hsu Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Yao-Lung Kuo Division of Plastic Surgery
- Shang-Hung Chen Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Junping Shiau Shiau Division of General Surgery
- Fang-Ming Chen Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Fu Ouyang Division of General Surgery
- Shen Liang Shih Division of General Surgery
- 高捷妮 Division of General Surgery
- 巫承哲 Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
360 participants
